FGF1 and metabolic dysfunction-associated steatotic liver disease: To investigate the role of FGF1 in MASLD, we conducted validation experiments to assess FGF1 expression in FFA-induced L02 cells, a MASLD mouse model, and liver tissues from patients with MASLD using qRT-PCR and western blotting.